Cypherpunk Purchases Additional $18 Million of ZEC, Bringing Total Network Percentage to 1.43%

About this update from Cypherpunk Technologies Inc.

[{"type":"text","content":"\n CAMBRIDGE, Mass., Nov. 18, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced the company has purchased an additional 29,869.29 ZEC for $18 million, at an average purchase price of $602.63 per ZEC. The company recently revealed its initial acquisition totaling 203,775.27 ZEC, purchased for approximately $50 million, at an average purchase price of $245.37 per ZEC. Now, with the new acquisition, Cypherpunk's total ZEC holdings stand at 233,644.56, at an average price of $291.04, bringing the company's total network ownership to 1.43%.\n Last week, Cypherpunk announced the appointment of veteran investor Khing Oei to its Board of Directors. The company also announced that Will McEvoy — a principal at Winklevoss Capital — is now serving on the Board and as Cypherpunk's Chief Investment Officer.\n \n Cypherpunk is a company dedicated to privacy and self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing commodity. Despite this, privacy enhancing technologies remain under-adopted. Backing privacy today is both a generational mission and a massive opportunity. Privacy is the foundation that allows freedom of speech, thought, and association to thrive. Without it, these freedoms exist only on paper and can't be exercised in practice in a meaningful way. In other words, privacy is the silent precondition of freedom.\n In a world where privacy is scarce, privacy becomes the most valuable commodity.\n \n Cypherpunk sees Zcash as digital privacy in asset form, the same way Bitcoin has proven to be digital gold. Zcash also represents an important hedge against the transparency of Bitcoin and the existing financial infrastructure in an AI-abundant future.\n \n About Cypherpunk\n \n Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. Following a $58.88 million private placement led by Winklevoss Capital, the Company is aiming to build long-term shareholder value by acquiring ZEC, participating in the development of Zcash, and continuing the development of sirexatamab and FL-501 to treat patients with cancer. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www....

More updates from Cypherpunk Technologies Inc.